Meningiomas Clinical Trial
Official title:
Effects of Scalp Nerve Blocks on Systemic Inflammation After Meningeoma Resection Surgery：a Prospective Randomized Controlled Trial
Patients undergoing meningeoma resection surgery will be randomly assigned to two groups. One group will receive scalp nerve blocks with 0.5% ropivacaine, whereas the other group will receive scalp nerve blocks with 0.9% saline after anesthesia induction and before skull-pin insertion. Serum levels of TNF-α、IL-6 and IL-1β will be measured and compared at before surgery, 1h, 24h and 72h after surgery, respectively. VAS score, dosage of pain-control medicine and NRS score at the first three days after surgery, ratio of intracranial infection within 30d after surgery, and total hospitalization days and medical expenditure will also be recorded and compared between the two groups.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT00517959 -
SCRT Versus Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumors
|
Phase 3 | |
| Recruiting |
NCT02648997 -
An Open-Label Phase II Study of Nivolumab in Adult Participants With Progessive/ Recurrent Meningioma
|
Phase 2 | |
| Completed |
NCT01880749 -
Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas
|
Early Phase 1 | |
| Not yet recruiting |
NCT06466720 -
Measuring and Mapping Cognitive Decline After Brain Radiosurgery
|
||
| Recruiting |
NCT01655927 -
Efficacy of Tranexamic Acid in Brain Tumor Resections
|
Phase 3 |